-
EDAP Reports Q4 EPS EUR 0.14
Tuesday, March 29, 2011 - 8:31am | 130EDAP TMS SA (Nasdaq: EDAP), announced today financial results for the fourth quarter and full year ended December 31, 2010. Total revenue for the fourth quarter 2010 was EUR 8.0 million (USD 10.8 million), as compared to EUR 8.1 million (USD 11.9 million) for the fourth quarter 2009. Operating...
-
Jefferies Initiating Coverage On DexCom At Buy
Tuesday, March 29, 2011 - 7:52am | 123According to Jefferies, DexCom (NASDAQ: DXCM) is initiated with a Buy rating. Jefferies reported that DexCom offers the Seven Plus Sensor to continuously monitor glucose levels, allowing patients to better manage their glucose levels. “Adoption of CGM technology is still in its infancy with the...
-
Oppenheimer Comments On Protecta Approval (MDT)
Tuesday, March 29, 2011 - 7:25am | 124Medtronic, Inc. (NYSE: MDT) announced yesterday afternoon FDA approval for its Protecta XT ICD and CRT-D platform with shock-reduction capabilities, Oppenheimer reports. “The FDA nod follows the March 9 resolution of MDT's Mounds View, MN warning letter; the Protecta had been originally slated for...
-
Jefferies Initiates DexCom At Buy, $17 PT
Tuesday, March 29, 2011 - 7:10am | 24Jefferies & Company has initiated coverage on DexCom (NASDAQ: DXCM) with a Buy rating and $17 price target.
-
Software Radio Technology tracks down new contract wins in China
Tuesday, March 29, 2011 - 4:00am | 444Software Radio Technology (LON:SRT) , the company that makes maritime communications systems and tracking equipment, has received orders from two Chinese customers totalling US$300,000. The orders are important for SRT because they mark the latest steps in the company's efforts to make serious...
-
Inflation is on the Brain 03-28-2011
Monday, March 28, 2011 - 7:02pm | 864Cusick's Corner Inflation is on the brain and with the Hawks circling, this market needs leadership to arise before any real money is going to work. With that said, we may have this choppy action until the jobs data comes in at the end of this week. The Consumer Confidence Number will be a big one...
-
Synovis Life Technologies Inc. CEO Sells 25,735 Shares of SYNO
Monday, March 28, 2011 - 4:40pm | 53In a Form 4 filed earlier today, Synovis Life Technologies Inc. (NASDAQ: SYNO) CEO, Rich Kramp, reported that he sold 25,735 shares of SYNO on March 24th-28th for an average price of $19.56. The transaction totaled $503,328. Mr. Kramp owns 35,962 direct shares of SYNO. Source: The Washington...
-
Trading Resumes: IVAX Diagnostics
Monday, March 28, 2011 - 3:09pm | 14Trading Resumes: IVAX Diagnostics (NYSE: IVD)
-
IVAX Diagnostics, Inc. Reports Q4 EPS of $(0.03)
Monday, March 28, 2011 - 3:00pm | 127IVAX Diagnostics, Inc. (NYSE: IVD) reports its financial results for the fourth quarter and full year ended December 31, 2010. For the quarter ended December 31, 2010, net revenue was $4.0 million compared with $4.5 million in the quarter ended December 31, 2009. Gross profit for the quarter...
-
Trading Halted: IVAX Diagnostics, News pending (IVD)
Monday, March 28, 2011 - 2:49pm | 16Trading Halted: IVAX Diagnostics (NYSE: IVD), News pending
-
Medtronic Announces FDA Approval of Protecta Implantable Defibrillators That Reduce Inappropriate Shocks
Monday, March 28, 2011 - 2:30pm | 115Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Protecta portfolio of implantable cardioverter-defibrillatorsand cardiac resynchronization therapy-defibrillators. The new family of implantable defibrillators features SmartShock™ Technology,...
-
Puts Purchased on Clinical Data, Inc. (CLDA)
Monday, March 28, 2011 - 1:16pm | 158Shares of Clinical Data, Inc. (NASDAQ: CLDA) are lower on the session by 0.10%, currently trading at $30.32. The stock had been moving largely sideways over the past three months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on the name...
-
EnteroMedics Receives CE Mark Certification for the Maestro RC System, Allowing Australian Regulatory Application to Move Forward
Monday, March 28, 2011 - 9:07am | 190EnteroMedics (NASDAQ: ETRM), the sole developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that it has received CE Mark approval of its second generation Maestro RC System for the treatment of obesity using VBLOC vagal...
-
Rockwell Medical Announces New Supply Agreement With DaVita Inc.
Monday, March 28, 2011 - 7:43am | 26Rockwell Medical (Nasdaq: RMTI) announced today that it has executed a multi-year supply agreement with DaVita Inc. through 2013.
-
Morgan Stanley Increases HSP 1Q11 Estimates
Friday, March 25, 2011 - 9:36am | 83Morgan Stanley has increased its first quarter estimates for Hospira (NYSE: HSP). According to the report, “We are increasing our 1Q EPS estimate to $0.79 from $0.65 and revenues from $893MM to $939MM more or less in-line with the updated guidance. For the full year, our EPS estimate rises to $4....